Maria Claudia Nogueira Zerbini
Overview
Explore the profile of Maria Claudia Nogueira Zerbini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
411
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
22.
Vianna P, Pastore P, Cristofani L, Siqueira S, Aldred V, de Campos F, et al.
Autops Case Rep
. 2019 Sep;
2(3):39-44.
PMID: 31528578
First described by Dr. Benjamin Castleman in 1956, Castleman disease is an uncommon disease of an etiology that is not yet thoroughly known. Three distinct histological subtypes have already been...
23.
Felipe-Silva A, de Campos F, de Medeiros R, Lourencao R, Zerbini M
Autops Case Rep
. 2019 Sep;
2(2):31-36.
PMID: 31528569
Enteropathy-associated T-cell Lymphoma (EATL) is a rare form of aggressive T-cell lymphoma. It is more prevalent in men over 60 years and the prognosis is very poor. EATL is classified...
24.
de Campos F, Lima P, Lima F, Braz Simoes A, Kim E, Smeili L, et al.
Autops Case Rep
. 2019 Sep;
2(2):11-20.
PMID: 31528566
Hemophagocytic lymphohistiocytosis (HLH) is an uncommon life-threatening disorder characterized by wide spread non-neoplastic proliferation and inappropriate activation of mature macrophages resulting in hypercytokinemia. This uncontrollable and ineffective systemic immune response...
25.
Ferreira C, Lima F, Goto E, Kim E, Smeili L, de Campos F, et al.
Autops Case Rep
. 2019 Sep;
1(4):11-20.
PMID: 31528548
Acute erythroid leukemia (AEL) is a rare subtype of acute myeloid leukemia (AML), characterized by predominant erythroid proliferation. The 2008 World Health Organization (WHO) classification of AML defined two AEL...
26.
Lage L, Levy D, Xavier F, Reis D, Costa R, Goncalves M, et al.
Oncotarget
. 2019 Sep;
10(50):5136-5151.
PMID: 31497245
Nodal peripheral T-cell lymphoma (PTCL) is an aggressive and heterogeneous malignancy with poor prognosis. We studied the prognostic impact of the expression profile of genes related to cell proliferation (,...
27.
Passaia B, Lima K, Kremer J, Conceicao B, Mariani B, Lipreri da Silva J, et al.
Invest New Drugs
. 2019 Aug;
38(3):899-908.
PMID: 31441020
Adrenocortical carcinoma (ACC) is an aggressive endocrine cancer with few molecular predictors of malignancy and survival, especially in paediatric patients. Stathmin 1 (STMN1) regulates microtubule dynamics and has been involved...
28.
Lage L, Hamasaki D, Moreira F, Rocha V, Zerbini M, Pereira J
Ann Hematol
. 2019 Jun;
98(9):2097-2102.
PMID: 31243570
Nodal peripheral T cell lymphomas (nPTCL) present aggressive clinical course, and its heterogeneous nature and poor prognosis with current therapeutic strategies make it a target for the development of new...
29.
Ferreira A, Brondani V, Helena V, Charchar H, Zerbini M, Leite L, et al.
J Steroid Biochem Mol Biol
. 2019 Apr;
190:250-255.
PMID: 30974190
Background: The TP53 p.R337H germline mutation is highly prevalent among children with adrenocortical tumors (ACTs) from South and Southeast Brazil. However, the prevalence of other tumors of the Li-Fraumeni syndrome...
30.
Moreira-Filho C, Bando S, Bernardi Bertonha F, Ferreira L, Vinhas C, Oliveira L, et al.
Sci Rep
. 2018 Sep;
8(1):13169.
PMID: 30177771
AIRE expression in thymus is downregulated by estrogen after puberty, what probably renders women more susceptible to autoimmune disorders. Here we investigated the effects of minipuberty on male and female...